Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dasiglucagon for postprandial hypoglycaemia after Roux-en-Y gastric bypass
2019-001915-22Phase 2Completed
- Sponsor
- Center for Diabetes Research
- Start
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, single-arm trial of dasiglucagon in Postprandial hyperinsulinemic hypoglycemia (PHH), sponsored by Center for Diabetes Research. Primary endpoint: Postprandial nadir plasma glucose concentration. Started Jun 2019; status: completed.
02
Drugs
dasiglucagon
03
Conditions
Postprandial hyperinsulinemic hypoglycemia (PHH)
Beyond the preview
Go deeper on 2019-001915-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001915-22.